Picture of AVITA Medical logo

RCEL — AVITA Medical News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Avita Medical Inc Reports Results For The Quarter Ended In March: Earnings Summary

* AVITA Medical Inc  RCEL.OQ  reported a quarterly adjusted
loss
of 37 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 25 cents per share.
    * Revenue rose 39.9% to $10.55 million from a year ago;
analysts
expected $10.33 million. 
    * AVITA Medical Inc's reported EPS for the quarter was a
loss
of 37 cents​.
    * The mean earnings estimate of analysts had risen by
about 13.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * AVITA Medical Inc shares had risen by 14.7% this
quarter and
gained 142.9% so far this year.
    * The company reported a quarterly loss of $9.22 million.
    * Wall Street's median 12-month price target for AVITA
Medical Inc
is $18.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 03:43 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.25          -0.37          Missed
 Dec. 31 2022      -0.29          -0.22          Beat
 Sep. 30 2022      -0.34          -0.22          Beat
 Jun. 30 2022      -0.39          -0.25          Beat

Recent news on AVITA Medical

See all news